Publications found:
55,654
Sort by:
Acromegaly - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Acromegaly pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Acromegaly pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
80 pages
Acute Kidney Injury - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... . Report assists users in taking actionable steps Acute Kidney Injury pipeline report enables users to gain clear understanding into ... business in Acute Kidney Injury treatment pipeline. The report includes: The research work provides comprehensive overview of Acute Kidney Injury pipeline and treatment ...
April 2019
140 pages
Acute Renal Failure (ARF) - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments associated with each drug. Companies participating in Acute Renal Failure (ARF) pipeline Profiled in detail Key players actively ... business in Acute Renal Failure (ARF) treatment pipeline. The report includes: The research work provides comprehensive overview of Acute Renal Failure (ARF) pipeline ...
April 2019
144 pages
Alcoholic Hepatitis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments associated with each drug. Companies participating in Alcoholic Hepatitis pipeline Profiled in detail Key ... Alcoholic Hepatitis treatment pipeline. The report includes: The research work provides comprehensive overview of Alcoholic Hepatitis pipeline and treatment landscape Complete list of drug ...
April 2019
65 pages
Amyloidosis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Amyloidosis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Amyloidosis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
100 pages
Anaphylaxis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Anaphylaxis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Anaphylaxis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
40 pages
Benign Prostatic Hyperplasia - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... Report assists users in taking actionable steps Benign Prostatic Hyperplasia pipeline report enables users to gain clear understanding ... in Benign Prostatic Hyperplasia treatment pipeline. The report includes: The research work provides comprehensive overview of Benign Prostatic Hyperplasia pipeline and ...
April 2019
89 pages
Birch Pollen Allergy - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... . Report assists users in taking actionable steps Birch Pollen Allergy pipeline report enables users to gain clear understanding into ... business in Birch Pollen Allergy treatment pipeline. The report includes: The research work provides comprehensive overview of Birch Pollen Allergy pipeline and treatment ...
April 2019
50 pages
Cat Allergy - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Cat Allergy pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
35 pages
Cedar Pollen Allergy - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... . Report assists users in taking actionable steps Cedar Pollen Allergy pipeline report enables users to gain clear understanding into ... business in Cedar Pollen Allergy treatment pipeline. The report includes: The research work provides comprehensive overview of Cedar Pollen Allergy pipeline and treatment ...
April 2019
40 pages
Celiac Disease - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Celiac Disease pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
88 pages
Cervical Intraepithelial Neoplasia (CIN) - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... with each drug. Companies participating in Cervical Intraepithelial Neoplasia (CIN) pipeline Profiled in detail Key players ... Cervical Intraepithelial Neoplasia (CIN) treatment pipeline. The report includes: The research work provides comprehensive overview of Cervical Intraepithelial Neoplasia (CIN) ...
April 2019
72 pages
Colitis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Colitis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Colitis pipeline and treatment landscape Complete list of drug candidates from discovery to pre-registration ...
April 2019
100 pages
Constipation - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... recent developments associated with each drug. Companies participating in Constipation pipeline Profiled in detail Key players actively participating in constipation pipeline are profiled along with their ...
April 2019
77 pages
Contrast Induced Nephropathy - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... Report assists users in taking actionable steps Contrast Induced Nephropathy pipeline report enables users to gain clear understanding ... in Contrast Induced Nephropathy treatment pipeline. The report includes: The research work provides comprehensive overview of Contrast Induced Nephropathy pipeline and ...
April 2019
35 pages
Cushing Syndrome - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments, pharmacological action and recent developments associated with each drug. Companies participating in Cushing Syndrome pipeline Profiled in detail Key players actively participating in constipation ...
April 2019
58 pages
Diabetic Foot Ulcers - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... . Report assists users in taking actionable steps Diabetic Foot Ulcers pipeline report enables users to gain clear understanding into ... business in Diabetic Foot Ulcers treatment pipeline. The report includes: The research work provides comprehensive overview of Diabetic Foot Ulcers pipeline and treatment ...
April 2019
145 pages
Diabetic Gastroparesis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... associated with each drug. Companies participating in Diabetic Gastroparesis pipeline Profiled in detail Key ... Diabetic Gastroparesis treatment pipeline. The report includes: The research work provides comprehensive overview of Diabetic Gastroparesis pipeline and treatment landscape Complete list of drug ...
April 2019
55 pages
Diabetic Neuropathy - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... developments associated with each drug. Companies participating in Diabetic Neuropathy pipeline Profiled in detail Key ... Diabetic Neuropathy treatment pipeline. The report includes: The research work provides comprehensive overview of Diabetic Neuropathy pipeline and treatment landscape Complete list of drug ...
April 2019
130 pages
Diabetic Peripheral Neuropathy - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... Report assists users in taking actionable steps Diabetic Peripheral Neuropathy pipeline report enables users to gain clear understanding ... in Diabetic Peripheral Neuropathy treatment pipeline. The report includes: The research work provides comprehensive overview of Diabetic Peripheral Neuropathy pipeline and ...
April 2019
81 pages
Diarrhea - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Diarrhea pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Diarrhea pipeline and treatment landscape Complete list of drug candidates from discovery to pre-registration ...
April 2019
142 pages
End Stage Kidney Disease - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... associated with each drug. Companies participating in End Stage Kidney Disease pipeline Profiled in detail Key players actively participating ... in End Stage Kidney Disease treatment pipeline. The report includes: The research work provides comprehensive overview of End Stage Kidney Disease pipeline ...
April 2019
42 pages
End Stage Renal Disease (ESRD) - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... associated with each drug. Companies participating in End Stage Renal Disease (ESRD) pipeline Profiled in detail Key players actively ... in End Stage Renal Disease (ESRD) treatment pipeline. The report includes: The research work provides comprehensive overview of End Stage Renal Disease (ESRD) pipeline ...
April 2019
40 pages
Endometriosis - Pipeline Drugs and Companies, Q2 2019
US$ 1,799.00
... action and recent developments associated with each drug. Companies participating in Endometriosis pipeline Profiled in detail Key players actively participating ... work provides comprehensive overview of Endometriosis pipeline and treatment landscape Complete list of drug candidates from discovery to pre- ...
April 2019
130 pages